Literature DB >> 8405056

Dynamic response of murine gut intraepithelial T cells after infection by the coccidian parasite Eimeria.

R C Findly1, S J Roberts, A C Hayday.   

Abstract

The response of murine intraepithelial lymphocyte (IEL) populations to challenge by Eimeria vermiformis, a naturally occurring protozoan parasite of the gut epithelium, has been studied. The number of recoverable IEL increased within 3 days post infection, was depleted by day 7 post infection, but was significantly increased again by about day 14 post infection. Special attention was paid to gamma delta+ IEL T cells, because they are of unknown functions. These cells showed changes in numbers similar to the total IEL population. Moreover, by day 3, increased expression was detected among gamma delta+ IEL T cells, of T cell receptor genes not constitutively associated with the intestine. These results demonstrate that the IEL repertoire, and within that, the gamma delta+ T cell repertoire, can be extremely dynamic post infection with a naturally occurring epithelial-tropic pathogen. In considering the potential benefits of such IEL changes, we hypothesize that they may be relevant to the transient protection of the host's epithelium, both from parasitic re-infection, and from potentially damaging inflammation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405056     DOI: 10.1002/eji.1830231027

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

Review 1.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes.

Authors:  V McDonald; H A Robinson; J P Kelly; G J Bancroft
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells.

Authors:  H Komano; Y Fujiura; M Kawaguchi; S Matsumoto; Y Hashimoto; S Obana; P Mombaerts; S Tonegawa; H Yamamoto; S Itohara
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

4.  Disruption of epithelial gamma delta T cell repertoires by mutation of the Syk tyrosine kinase.

Authors:  C A Mallick-Wood; W Pao; A M Cheng; J M Lewis; S Kulkarni; J B Bolen; B Rowley; R E Tigelaar; T Pawson; A C Hayday
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 5.  Intestinal intraepithelial T lymphocytes. Our T cell horizons are expanding.

Authors:  M Nanno; Y Kanamori; H Saito; M Kawaguchi-Miyashita; S Shimada; H Ishikawa
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

6.  Development and cytolytic function of intestinal intraepithelial T lymphocytes in antigen-minimized mice.

Authors:  M Kawaguchi-Miyashita; K Shimizu; M Nanno; S Shimada; T Watanabe; Y Koga; Y Matsuoka; H Ishikawa; K Hashimoto; M Ohwaki
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

7.  An alphabeta T-cell-independent immunoprotective response towards gut coccidia is supported by gammadelta cells.

Authors:  A L Smith; A C Hayday
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

8.  T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium.

Authors:  S J Roberts; A L Smith; A B West; L Wen; R C Findly; M J Owen; A C Hayday
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 9.  Gamma delta T-cell help in responses to pathogens and in the development of systemic autoimmunity.

Authors:  L Wen; A C Hayday
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

10.  T-cell receptor gamma--delta lymphocytes and Eimeria vermiformis infection.

Authors:  M E Rose; P Hesketh; L Rothwell; R A Gramzinski
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.